Header Logo

Heidi Klepin

Concepts (291)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
25
2019
176
9.840
Why?
Geriatric Assessment
28
2019
361
6.770
Why?
Neoplasms
32
2019
645
4.830
Why?
Geriatrics
12
2019
112
4.060
Why?
Medical Oncology
12
2019
69
3.100
Why?
Antineoplastic Agents
14
2018
573
2.530
Why?
Aged
73
2019
9960
2.270
Why?
Comorbidity
19
2018
555
1.770
Why?
Aged, 80 and over
38
2018
3881
1.620
Why?
Humans
85
2019
28875
1.570
Why?
Activities of Daily Living
10
2019
238
1.540
Why?
Breast Neoplasms
8
2018
719
1.470
Why?
Age Factors
23
2019
1183
1.430
Why?
Aging
9
2019
935
1.410
Why?
Myelodysplastic Syndromes
3
2016
27
1.390
Why?
Cognition
7
2018
538
1.290
Why?
Hematologic Neoplasms
2
2017
28
1.240
Why?
Chemotherapy, Adjuvant
5
2018
174
1.070
Why?
Antineoplastic Combined Chemotherapy Protocols
9
2018
433
1.030
Why?
Polypharmacy
4
2018
19
1.020
Why?
Evidence-Based Medicine
3
2018
193
0.990
Why?
Disease Management
3
2019
128
0.950
Why?
Female
53
2019
18753
0.940
Why?
Hematologic Diseases
2
2018
23
0.930
Why?
Carcinoma, Non-Small-Cell Lung
2
2018
108
0.830
Why?
Fellowships and Scholarships
2
2017
48
0.830
Why?
Quality of Life
13
2018
842
0.820
Why?
Hyperglycemia
2
2018
86
0.800
Why?
Carboplatin
2
2018
47
0.790
Why?
Prognosis
10
2019
1402
0.780
Why?
Male
45
2019
18439
0.780
Why?
Depression
4
2018
381
0.780
Why?
Accidental Falls
2
2018
82
0.760
Why?
Early Detection of Cancer
1
2019
64
0.760
Why?
Paclitaxel
1
2018
82
0.740
Why?
Treatment Outcome
12
2019
3145
0.720
Why?
Hospitalization
4
2018
364
0.700
Why?
Health Services for the Aged
2
2015
28
0.690
Why?
Patient Care Management
1
2016
17
0.690
Why?
Clinical Trials as Topic
6
2019
324
0.680
Why?
Prospective Studies
17
2019
2013
0.670
Why?
Risk Assessment
5
2018
1348
0.670
Why?
Physician's Role
1
2016
48
0.660
Why?
Multiple Myeloma
3
2018
23
0.660
Why?
Middle Aged
24
2018
11429
0.660
Why?
Blood Glucose
1
2018
499
0.620
Why?
Lung Neoplasms
2
2018
389
0.600
Why?
Proportional Hazards Models
6
2018
765
0.600
Why?
Cognition Disorders
3
2015
417
0.590
Why?
Physical Fitness
1
2014
120
0.550
Why?
Tamoxifen
1
2013
53
0.540
Why?
Risk Factors
12
2019
3669
0.510
Why?
Social Support
4
2016
160
0.510
Why?
Bone Marrow Transplantation
1
2013
77
0.510
Why?
Adaptation, Psychological
1
2013
125
0.480
Why?
Exercise
5
2019
568
0.480
Why?
Medication Adherence
1
2013
136
0.480
Why?
Disability Evaluation
4
2016
224
0.460
Why?
Survival Rate
6
2018
840
0.460
Why?
Hand Strength
2
2010
88
0.440
Why?
Retrospective Studies
10
2018
2944
0.440
Why?
Exercise Therapy
1
2013
221
0.430
Why?
Combined Modality Therapy
4
2019
558
0.420
Why?
Walking
2
2010
176
0.420
Why?
Cardiovascular Diseases
2
2015
1092
0.410
Why?
Hematopoietic Stem Cell Transplantation
4
2018
88
0.400
Why?
Survivors
3
2016
150
0.400
Why?
Healthcare Disparities
3
2019
123
0.380
Why?
Randomized Controlled Trials as Topic
4
2018
448
0.350
Why?
Colorectal Neoplasms
3
2015
230
0.340
Why?
Heart Ventricles
2
2018
147
0.330
Why?
Multivariate Analysis
5
2015
701
0.330
Why?
Esthesioneuroblastoma, Olfactory
1
2005
2
0.320
Why?
Nasal Cavity
1
2005
5
0.320
Why?
Nose Neoplasms
1
2005
3
0.320
Why?
Mobility Limitation
2
2018
189
0.320
Why?
United States
11
2018
3712
0.310
Why?
Diabetes Mellitus, Type 2
1
2015
1578
0.310
Why?
Logistic Models
4
2015
773
0.300
Why?
Adult
12
2018
8635
0.300
Why?
Curriculum
2
2017
204
0.300
Why?
Mental Health
2
2016
108
0.300
Why?
Stroke Volume
2
2018
311
0.290
Why?
Stem Cell Transplantation
1
2006
209
0.290
Why?
Longitudinal Studies
7
2018
744
0.270
Why?
Cohort Studies
7
2019
1725
0.270
Why?
Nutrition Assessment
2
2016
66
0.260
Why?
Radiotherapy, Conformal
1
2011
24
0.250
Why?
United States Food and Drug Administration
2
2018
43
0.240
Why?
SEER Program
2
2019
37
0.230
Why?
Anthracyclines
2
2018
54
0.230
Why?
Frail Elderly
2
2017
62
0.220
Why?
Inpatients
2
2018
49
0.220
Why?
Societies, Medical
2
2018
142
0.210
Why?
Motor Activity
2
2013
331
0.210
Why?
Patient Satisfaction
1
2011
216
0.210
Why?
Physician-Patient Relations
1
2011
181
0.210
Why?
Risk
3
2016
307
0.200
Why?
Neoplasm Staging
5
2017
436
0.200
Why?
Morbidity
1
2019
95
0.200
Why?
Anemia
2
2017
54
0.200
Why?
Behavioral Symptoms
1
2018
2
0.200
Why?
Cross-Sectional Studies
4
2018
1356
0.190
Why?
Ventricular Dysfunction, Left
2
2018
192
0.190
Why?
Resilience, Psychological
1
2018
12
0.190
Why?
Vision Disorders
1
2018
20
0.190
Why?
Hearing Loss
1
2018
18
0.190
Why?
Patient Preference
1
2018
34
0.190
Why?
Fluorouracil
2
2017
84
0.180
Why?
Hematology
1
2017
5
0.180
Why?
Resuscitation Orders
1
2017
13
0.180
Why?
Salvage Therapy
2
2015
118
0.180
Why?
Cardiac Volume
1
2017
12
0.180
Why?
Exercise Movement Techniques
1
2016
2
0.180
Why?
Oncology Service, Hospital
1
2016
4
0.180
Why?
Career Mobility
1
2017
18
0.170
Why?
Mastectomy
1
2017
67
0.170
Why?
Leukemia
1
2017
44
0.170
Why?
Education
1
2016
32
0.170
Why?
Neoplasms, Second Primary
1
2016
15
0.170
Why?
Medicine
1
2017
35
0.170
Why?
Disease-Free Survival
2
2014
292
0.170
Why?
Interdisciplinary Communication
1
2016
52
0.170
Why?
Prostatic Neoplasms
1
2011
411
0.170
Why?
Decision Making
2
2018
183
0.170
Why?
Nutrition Disorders
1
2016
16
0.170
Why?
Intensive Care Units
1
2017
124
0.170
Why?
Diet
1
2019
372
0.170
Why?
Transplantation, Homologous
2
2015
123
0.170
Why?
Physical Examination
1
2016
74
0.160
Why?
Life Expectancy
1
2016
19
0.160
Why?
Research
1
2016
80
0.160
Why?
Pancreatic Neoplasms
1
2017
129
0.160
Why?
Patient Discharge
1
2016
165
0.160
Why?
Time Factors
4
2017
2087
0.150
Why?
Drug Dosage Calculations
1
2015
8
0.150
Why?
Medicaid
2
2012
76
0.150
Why?
Biomedical Research
1
2017
164
0.150
Why?
Diabetes Mellitus
1
2018
427
0.150
Why?
Ventricular Function, Left
1
2017
252
0.150
Why?
Interprofessional Relations
1
2015
57
0.150
Why?
Nutritional Status
1
2015
73
0.140
Why?
Clinical Competence
1
2017
301
0.140
Why?
Research Design
1
2016
280
0.140
Why?
Deoxycytidine
1
2014
69
0.140
Why?
Adenocarcinoma
1
2017
296
0.140
Why?
Feasibility Studies
2
2012
261
0.140
Why?
Portraits as Topic
1
2013
4
0.140
Why?
Anticarcinogenic Agents
1
2013
24
0.140
Why?
Azacitidine
1
2013
30
0.140
Why?
Women's Health
1
2016
223
0.140
Why?
CA-125 Antigen
1
2013
5
0.140
Why?
Fallopian Tube Neoplasms
1
2013
6
0.140
Why?
Regression Analysis
1
2014
308
0.140
Why?
Kidney Diseases
1
2016
243
0.140
Why?
Affective Symptoms
1
2013
14
0.130
Why?
Predictive Value of Tests
2
2013
802
0.130
Why?
European Continental Ancestry Group
1
2019
1353
0.130
Why?
Molecular Diagnostic Techniques
1
2013
5
0.130
Why?
North Carolina
3
2018
1746
0.130
Why?
Anxiety
1
2014
156
0.130
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2013
21
0.130
Why?
Prevalence
4
2018
963
0.130
Why?
Secondary Prevention
1
2013
61
0.130
Why?
DNA Methylation
1
2013
137
0.130
Why?
Colonoscopy
1
2012
44
0.120
Why?
Ovarian Neoplasms
1
2013
95
0.120
Why?
Plant Preparations
1
2012
25
0.120
Why?
Adiposity
1
2013
202
0.120
Why?
Nonprescription Drugs
1
2012
29
0.120
Why?
Neuropsychological Tests
1
2013
401
0.120
Why?
Health Services Accessibility
2
2012
236
0.120
Why?
Nursing Assessment
1
2011
10
0.120
Why?
Inflammation
1
2015
512
0.120
Why?
Heart Failure
1
2018
645
0.120
Why?
Follow-Up Studies
5
2017
2180
0.120
Why?
Insurance Coverage
1
2012
68
0.120
Why?
Postmenopause
1
2013
412
0.120
Why?
Coronary Artery Disease
1
2015
459
0.110
Why?
Extremities
1
2011
39
0.110
Why?
Radiotherapy, Adjuvant
1
2011
69
0.110
Why?
Sarcoma
1
2011
40
0.110
Why?
Colonic Neoplasms
1
2011
70
0.110
Why?
Dietary Supplements
1
2012
180
0.110
Why?
Poverty
1
2011
100
0.110
Why?
African Americans
1
2019
1633
0.110
Why?
Mass Screening
1
2012
201
0.110
Why?
Peritoneal Neoplasms
1
2013
251
0.100
Why?
Practice Guidelines as Topic
1
2013
374
0.100
Why?
Disabled Persons
1
2010
84
0.100
Why?
Heart Failure, Diastolic
1
2009
21
0.100
Why?
Health Status Indicators
1
2009
76
0.100
Why?
Mentors
1
2008
31
0.090
Why?
Tomography, X-Ray Computed
1
2013
933
0.090
Why?
Faculty, Medical
1
2008
75
0.090
Why?
Obesity
1
2015
1093
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2009
118
0.090
Why?
Transplantation, Autologous
1
2006
83
0.080
Why?
Algorithms
1
2009
457
0.080
Why?
Body Composition
2
2019
365
0.080
Why?
Kidney Transplantation
1
2009
353
0.070
Why?
Remission Induction
2
2015
87
0.070
Why?
Linear Models
2
2015
453
0.070
Why?
Kidney Failure, Chronic
1
2009
560
0.070
Why?
Body Mass Index
2
2019
920
0.060
Why?
Incidence
2
2015
1144
0.060
Why?
Diffusion of Innovation
1
2019
26
0.050
Why?
Validation Studies as Topic
1
2018
10
0.050
Why?
Treatment Refusal
1
2018
15
0.050
Why?
Forecasting
1
2019
139
0.050
Why?
Fatigue
1
2018
73
0.050
Why?
Vomiting
1
2018
35
0.050
Why?
Antibiotics, Antineoplastic
1
2018
70
0.050
Why?
Protein Kinase Inhibitors
1
2018
84
0.050
Why?
Needs Assessment
1
2018
65
0.050
Why?
Nausea
1
2018
68
0.050
Why?
Canada
1
2017
50
0.050
Why?
Hypoalbuminemia
1
2017
10
0.040
Why?
Antimetabolites, Antineoplastic
1
2017
54
0.040
Why?
Lymphopenia
1
2017
13
0.040
Why?
Feeding Behavior
1
2019
174
0.040
Why?
Sensation Disorders
1
2017
14
0.040
Why?
Hypokalemia
1
2017
16
0.040
Why?
Leucovorin
1
2017
24
0.040
Why?
Mastectomy, Segmental
1
2017
27
0.040
Why?
Neutropenia
1
2017
27
0.040
Why?
Patient Transfer
1
2017
32
0.040
Why?
Thrombocytopenia
1
2017
34
0.040
Why?
Maximum Tolerated Dose
1
2017
59
0.040
Why?
Sulfides
1
2017
28
0.040
Why?
Caprylates
1
2017
29
0.040
Why?
Organoplatinum Compounds
1
2017
46
0.040
Why?
Camptothecin
1
2017
50
0.040
Why?
Drug Therapy, Combination
1
2018
306
0.040
Why?
Abdominal Pain
1
2017
48
0.040
Why?
Creatine
1
2016
5
0.040
Why?
Mind-Body Therapies
1
2016
13
0.040
Why?
Health Behavior
1
2019
251
0.040
Why?
Models, Theoretical
1
2018
138
0.040
Why?
National Institute on Aging (U.S.)
1
2016
7
0.040
Why?
Kidney Function Tests
1
2016
103
0.040
Why?
Magnetic Resonance Imaging, Cine
1
2017
78
0.040
Why?
National Cancer Institute (U.S.)
1
2016
17
0.040
Why?
Life Style
1
2019
383
0.040
Why?
Consensus
1
2016
62
0.040
Why?
Diastole
1
2017
144
0.040
Why?
Hemoglobins
1
2015
42
0.040
Why?
Asparaginase
1
2015
5
0.040
Why?
Glomerular Filtration Rate
1
2016
294
0.040
Why?
Sepsis
1
2017
138
0.040
Why?
Mitoxantrone
1
2015
19
0.040
Why?
DNA Helicases
1
1995
5
0.040
Why?
Recombination, Genetic
1
1995
20
0.040
Why?
Cytarabine
1
2015
56
0.040
Why?
Health Surveys
1
2016
207
0.040
Why?
Escherichia coli Proteins
1
1995
26
0.040
Why?
DNA Repair
1
1995
50
0.040
Why?
Chi-Square Distribution
1
2015
312
0.040
Why?
Escherichia coli
1
1995
79
0.040
Why?
Coronary Angiography
1
2015
175
0.040
Why?
Interleukin-6
1
2015
240
0.040
Why?
Recurrence
1
2015
235
0.040
Why?
Body Weight
1
2016
301
0.040
Why?
Dose-Response Relationship, Drug
1
2016
668
0.040
Why?
Drug Administration Schedule
1
2015
271
0.040
Why?
Patient Selection
1
2016
262
0.040
Why?
Tumor Necrosis Factor-alpha
1
2015
200
0.040
Why?
C-Reactive Protein
1
2015
257
0.040
Why?
DNA-Binding Proteins
1
1995
142
0.040
Why?
Drug Evaluation
1
2013
10
0.040
Why?
Survival Analysis
1
2015
472
0.030
Why?
Body Fat Distribution
1
2013
40
0.030
Why?
Chronic Disease
1
2015
387
0.030
Why?
DNA, Neoplasm
1
2013
59
0.030
Why?
Absorptiometry, Photon
1
2013
135
0.030
Why?
Health Status
1
2016
398
0.030
Why?
Cisplatin
1
2013
72
0.030
Why?
Disease Progression
1
2015
589
0.030
Why?
DNA Damage
1
2013
89
0.030
Why?
Neoplasm Proteins
1
2013
139
0.030
Why?
Health Knowledge, Attitudes, Practice
1
2016
336
0.030
Why?
Young Adult
1
2018
2415
0.030
Why?
Waiting Lists
1
2009
24
0.030
Why?
Severity of Illness Index
1
2009
898
0.020
Why?
Conjugation, Genetic
1
1995
1
0.010
Why?
RecQ Helicases
1
1995
1
0.010
Why?
Methyl Methanesulfonate
1
1995
3
0.010
Why?
Adenosine Triphosphatases
1
1995
11
0.010
Why?
Mutagenesis, Insertional
1
1995
15
0.010
Why?
Sequence Deletion
1
1995
36
0.010
Why?
Ultraviolet Rays
1
1995
44
0.010
Why?
Klepin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (291)
Explore
_
Co-Authors (44)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_